|

Parkinson's Disease Clinical Trials in San Jose, CA

22 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 416 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 316 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 416 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 216 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 316 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—16 mi
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 216 mi
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPhase 1/217 mi
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's DiseaseN/A17 mi
GBPDC: Gut-Brain in PD Consortium Master Protocol—17 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A22 mi
Parkinson's Foundation PD GENEration Genetic Registry—22 mi
Psilocybin Therapy for Depression in Parkinson's DiseasePhase 242 mi
Ketamine for Veterans With Parkinson's DiseasePhase 242 mi
Parkinson Progression Marker Initiative Online (PPMI Online)—42 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—42 mi
Understanding Motivation in Parkinson's Patients Through NeurophysiologyN/A42 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 242 mi
Safety and Usability of the Cionic Neural Sleeve for Parkinson's DiseaseN/A42 mi
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's DiseaseN/A42 mi
Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept NeurostimulatorN/A42 mi
Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's DiseaseN/A42 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.